Partnering With Brilliant People, Delivering Distributions, Recruiting An Analyst & Hopefully Improving Our World

/
Partnering With Brilliant People, Delivering Distributions, Recruiting An Analyst & Hopefully Improving Our World

We are thrilled to share that we have returned our LDV Capital I & II funds. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

We continue investing out of our LDV Capital IV fund. 

LPs say we are highly differentiated, disciplined, have high-quality sourcing and successfully create value by investing in category leaders at the earliest stages.

We are excited to be recruiting an Analyst to join our team to help us identify, analyze and evaluate investment opportunities. You will be a major contributor to all aspects of our fund from sourcing, market research, due diligence and supporting our portfolio companies.

Read More

To Be Successful in Business, You Have to Be Contrarian and Right

/
To Be Successful in Business, You Have to Be Contrarian and Right

Evan Nisselson first met Roelof Botha, Managing Partner and Steward of Sequoia Capital, while fundraising for his startup in 2005. Roelof said, “I think back to that meeting we had, and you had a vision for the future and the impact of visual, just imagery on consumer experiences was completely spot on.”

At our 10th Annual LDV Vision Summit, Roelof joined Evan for a fireside chat to discuss trends and early-stage investment opportunities in businesses leveraging visual technologies and AI. They spoke about Roelof’s insights from the ups and downs of the PayPal days, marshmallow tests, personality traits and much more!

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

/
The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

Meet Dr. Molly Gibson – Co-Founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, Origination Partner at Flagship Pioneering. LDV Capital's Founder & General Partner Evan Nisselson discussed with Molly how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials and more.

If you missed our 10th Annual LDV Vision Summit, this is your chance to watch the video or read our shortened & lightly edited transcript.

Read More

Meta’s Matt Uyttendaele on AI for Material Discovery

/
Meta’s Matt Uyttendaele on AI for Material Discovery

Matt Uyttendaele is the director of the AI for Chemistry group at Meta. His group applies machine learning to material discovery for several applications: clean hydrogen, sorbents for direct air capture, and next-generation displays. In 2024, we were honored to have him speak at our Annual General Meeting about a new application of AI that he has been working on for the last few years and how it relates to his career in visual technologies.

Read More

Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

/
Thank You For Celebrating Our 10th Anniversary LDV Vision Summit With Us!

We at LDV Capital celebrated our 10th LDV Vision Summit Anniversary! People from over 30 countries were part of our premier global gathering in visual tech & AI. We were thrilled to welcome speakers from Sequoia Capital, Wellville, Generate:Biomedicines, DCVC Bio, Princeton University, Stanford University, University of California, Nobias Therapeutics, Snap, Future Ventures, Meta, Axios and more. Two of our LDV Capital portfolio companies presented as well: Synthesia and Sonus Microsystems.

Read More

The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

/
The Age of New Medicines: How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials

On March 21, at our 10th Annual LDV Vision Summit, Evan Nisselson, Founder and General Partner at LDV Capital, will speak with Dr. Molly Gibson – Co-Founder and Chief Strategy and Innovation Officer at Generate:Biomedicines. They will discuss how AI and machine learning empower and disrupt the scientific process across life sciences, biotech, advanced materials, and more. This will have a tremendous impact on business and society. 

In the lead-up to the Summit, Evan had the privilege of asking Dr. Gibson a few questions.

Read More

LDV Capital Raised Fourth Fund To Continue Investing in People Building Businesses Powered by Visual Technologies and Artificial Intelligence

/

We are pleased to announce that we have raised our fourth LDV Capital fund with $31M. We will continue investing in the same unique thesis that has not changed since founding LDV Capital in 2012. The majority of data our brains analyze is visual so the majority of data that AI will analyze will be visual as well. Visual data and visual technologies are critical for the success of artificial intelligence horizontally across all sectors.

Read More

“The Difference Is – Now The Whole World Is Paying Attention To AI,” Says Prof. Serge Belongie

/
“The Difference Is – Now The Whole World Is Paying Attention To AI,” Says Prof. Serge Belongie

As we approach the 10th Annual LDV Vision Summit, we thought it fitting to pose a few burning questions to Serge Belongie, a professor of Computer Science at the University of Copenhagen, the head of the Danish Pioneer Centre for Artificial Intelligence and LDV Capital Expert in Residence. We delved into his experiences as a prominent figure in AI and sought his insights on the present landscape of visual technologies. Additionally, we explored his thoughts on the prospects available to researchers aiming to bring their work to market and impact humanity at large.

Read More

Congratulations to Synthesia On Their $90M Series C Led by Accel at a $1B Valuation

/
Congratulations to Synthesia On Their $90M Series C Led by Accel at a $1B Valuation

Synthesia, the market leader in AI video generation, announced their exciting $90 million Series C financing. The round is led by Philippe Botteri at Accel along with NVIDIA and existing investors. The company now officially hits unicorn status, and we are extremely proud of the brilliant co-founders, Victor Riparbelli, Steffen Tjerrild, Dr. Lourdes Agapito and Dr. Matthias Niessner, and the entire Synthesia team!

In April 2019, we led their Seed financing round when they were pre-product and pre-revenue. We met with 4 brilliant co-founders and were impressed with their big vision: to empower everyone to make video content without cameras, microphones, or studios. 

This milestone reinforces our belief in the transformative power of visual technologies and AI and their pivotal role in shaping the future. At LDV Capital, we are honored to have played a very small part in their incredible journey which continues to evolve every day.

Read More

Since 2012 - Timeline of Investing In People Building Businesses Powered by Visual Tech & AI

/
Since 2012 - Timeline of Investing In People Building Businesses Powered by Visual Tech & AI

Last year, we celebrated 10 years of investing in people building businesses powered by visual tech & AI, but it’s just the beginning! Visual technology innovations will continue to be the crux of automation for decades and beyond. Computer vision, machine learning and AI will be the key enablers for innovation in healthcare, precision medicine, manufacturing, construction, agriculture, sustainability, and many more industries.

Read More

Partnering with Daimon Labs to Build the Next Generation of Large Language Model Chatbot with Human-Like Empathy

/
Partnering with Daimon Labs to Build the Next Generation of Large Language Model Chatbot with Human-Like Empathy

We are excited to partner and invest in the exceptional Daimon Labs team – deep tech founders building generative AI and large language models with human-like empathy. Their technological approach has resulted in being able to train state-of-the-art neural models on over a trillion data points to deliver AI that has memory and the ability to tailor conversations.

Read More

Why These 11 Brilliant Professors & Researchers Are Focusing on AI

/
Why These 11 Brilliant Professors & Researchers Are Focusing on AI

Which sectors over the next 10 years will have the most societal impact from research advancements leveraging visual technologies and artificial intelligence? In the lead-up to our 9th Annual LDV Vision Summit – the premier global gathering in visual tech – hosted virtually on March 28, we addressed this and 4 other burning questions to 11 brilliant professors & researchers.

Read More

LDV Community is Helping Each Other Succeed: February 2023 Happy Hour Photos

/
LDV Community is Helping Each Other Succeed: February 2023 Happy Hour Photos

Check out photographs from our most recent LDV Happy Hour event! We hosted 75 fantastic technology innovators, serial entrepreneurs, deep tech researchers and investors across the New York tech ecosystem (with one of our guests flying in from Boston)!

Read More

Generative AI As A Utility Will Empower SaaS Businesses

/
Generative AI As A Utility Will Empower SaaS Businesses

We at LDV Capital have been investing in AI for over 10 years to date, and have made 7 investments in teams building businesses leveraging Generative AI since 2018. We believe that this technology has significant commercial value as a utility that will empower SaaS businesses to disrupt legacy enterprises. Check out this article to learn more and see some examples of exponentially growing commercial applications in content creation, biotech and more.

Read More

LDV Capital - 10 Years Investing In People Building Businesses Powered by Visual Tech & AI

/
LDV Capital - 10 Years Investing In People Building Businesses Powered by Visual Tech & AI

We could not have accomplished this exciting milestone without our inspiring portfolio founders, experts, community members, co-investors and LDV LPs. Thank you!

Read More